Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Not Yet Recruiting

A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL

NCT05054465

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Soroka Medical Center Beersheba, Israel
  • Rambam Health Care Campus Haifa, Israel
  • Shaare Zedek Medical Center Jerusalem, Israel
  • Rabin Medical Center Petah Tikva, Israel
View Trial Details
Completed

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

NCT01503632

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 102 locations
View Trial Details
Completed

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

NCT00400946

Conditions
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +11 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States
  • James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States
  • Albert Einstein Cancer Center at Albert Einstein College of Medicine The Bronx, New York, United States
View Trial Details
Completed

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

NCT01087294

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • National Marrow Donor Program Minneapolis, Minnesota, United States
View Trial Details

Related conditions